Seminars in Oncology
Volume 34, Supplement 3 , Pages S10-S16, April 2007

New Generation of Molecular Prognostic and Predictive Tests for Breast Cancer

  • Lajos Pusztai

      Affiliations

    • Dr Pusztai owns stock in Nuvera Biosciences Inc, and has served as a consultant to Bristol-Myers Squibb Company and Roche Pharmaceuticals.
    • Corresponding Author InformationAddress reprint requests to Lajos Pusztai, MD, PhD, The University of Texas, M. D. Anderson Cancer Center, Department of Breast Medical Oncology, Unit 1354, PO Box 301439, Houston, TX 77230-1439
    • ,
  • Massimo Cristofanilli
    • ,
  • Soonmyung Paik

Departments of Breast Medical Oncology and Pathology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX; the Division of Pathology, National Surgical Adjuvant Breast and Bowel Program, Pittsburgh, PA.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0093-7754(07)00069-3

doi:10.1053/j.seminoncol.2007.03.015

Seminars in Oncology
Volume 34, Supplement 3 , Pages S10-S16, April 2007

Article Tools

* Image Usage & Resolution